Repeated LSPC treatment prolongs survival of and decreases PrP^Res accumulation in a subset of prion-infected mice. by Heather Bender (363996)

Firing rate decreases during rule-based decisions. by R. Becket Ebitz (7841318)

Anandamide decreases exploratory behavior in the large open field. by Adriaan W. Bruijnzeel (2605954)

DCT depletion leads to a significant decrease in HPV infection in HaCaTs. by Pınar Aksoy (3663211)

“…(B) DCT band intensity for control and DCT siRNA treated cells was normalized to corresponding actin measurements. DCT protein levels decreased by 57% in DCT siRNA treated cells. (C) HPV16 PsV infection significantly decreased in DCT knockdown HaCaTs in three independent experiments compared to control siRNA treated cells (two-tailed t-test, p-values: 0.00000135, 0.000017 and 0.0000000022). …”

Procaine decreases mineralization of osteo/odontoblasts differentiated from mesenchymal stem cells (MSC). by Carmen Herencia (172829)

Knockdown of VGLUT1 results in a concomitant decrease in synaptic expression of synapsin and synaptophysin. by Corbett T. Berry (296520)

“…(<b>E</b>) Synaptophysin was not decreased in KD neurons co-expressing VGLUT1 (<i>V1</i>, VGLUT1 expressing neurons; p = 0.940; n = 244 and 96 puncta from 13 and 9 axons for SCR and V1, respectively, from a representative experiment. …”

CHIP overexpression decreases α-syn oligomer levels. by Lorraine V. Kalia (355943)

MMR mutants show decreased mating-type silencing. by Qian Liu (135614)

“…The <i>sir1Δ</i> mutant obtained from the silencing screen was used as a positive control. <b>(C)</b> Deletion of MMR component gene <i>MSH6</i> didn’t affect mating type silencing. …”

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…(C) A375 melanoma cells were treated with 1.0 μM 5-, 8-, 10-, 12-,14-, or 16-TPP for 1.5 h and analyzed for DHE oxidation (* significant relative to control; p<0.05; n = 3 from 2 separate experiments; N = 6). …”

<i>csrnp1a</i> knockdown decreases the number of blood cells in circulation. by Jaime Espina (106906)

“…(I) qPCR with primers located in exon 2 and 3 of 24 hpf control embryos (C) and splicing morphants injected with two concentrations, 2,5 and 5 ng per embryo, showing the relative expression of <i>csrnp1a</i> message, which decreases significantly in a dose-dependent manner (t student p<0,01).…”

Low-dose cytarabine decreases division and promotes differentiation of O-2A/OPCs by Joerg Dietrich (35101)

Different response of visASCs to a micro-local oxygen concentration decrease in metabolically active sites of the adipose tissue. by Wilfredo Oliva-Olivera (301968)

“…However, hypox-visASCs from MS patients show a lower ability to actively participate in or stimulate the formation of microvascular structures, while they favor the accumulation of CD11C⁺ and CD163⁺ macrophages in the adipose tissue through their contribution to the increased tissue levels of MCP1. ↑ Increased response; <b>↓</b> Decreased response; → Hypox-visASCs main response NonMS: obese subjects without metabolic syndrome; MS: obese subjects with metabolic syndrome; visASC: visceral adipose tissue-derived multipotent mesenchymal cells; hypox-visASCs: visASC under hypoxia; NOX5: NADPH Oxidase 5; SDF1α: stromal cell-derived factor 1α; VEGF: vascular endothelial growth factor; MCP1: monocyte chemoattractant protein 1; CD11C⁺, CD163⁺: proinflammatory macrophage cell-surface markers.…”

Table S1 - Development of a Heat-Shock Inducible Gene Expression System in the Red Alga <i>Cyanidioschyzon merolae</i> by Nobuko Sumiya (648113)

Subjects:

Healthspan decreases in response to cell-associated factor LPS in a dose-dependent manner. by Gabriel M. Moore (8566113)

Nilotinib decreases viability and proliferation of HEI-193 cells in a dose-dependent manner. by Nesrin Sabha (127278)

“…*denotes significant value (<i>p</i><0.05), **denotes significant value (p<0.005) (A) Nilotinib decreased absorbance on MTS viability assay in both growth conditions. …”

A brief course of RAP treatment decreases markers of proliferation and increases markers of differentiation. by Karin M. Hardiman (555189)

“…<p><i>CDX2P-CreER^T2 Apc^fl/fl</i> mice were injected with TAM and monitored until polyposis was seen endoscopically, then the mice were treated with vehicle or RAP at 3 mg/kg concentration for periods of one, three, or five days (N = 5 per timepoint). (A) and (B) Immunostaining of distal colons from these mice or Cre negative <i>Apc^fl/fl</i> mice for phospho-mTOR and phospho-S6. …”

Overexpression of E2 decreases ORC2 occupancy at a known mammalian origin. by Marsha DeSmet (2513767)

Reversion to susceptibility was consistent with decreasing relative <i>vanA</i> copy number. by Samuel E. Blechman (19506884)

Expression of a phosphomimetic Hcm1 mutant decreases fitness in LiCl stress. by Michelle M. Conti (13514386)

A surgical operation to remove wing discs and hematopoietic organs decreased plasma PPO. by Yupu Diao (148422)